Vestal Point Capital »

Voyager Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Voyager Therapeutics (VYGR) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Voyager Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Voyager Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Voyager Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.7M 600k 7.91

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Voyager Therapeutics

BlackRock
Armistice Capital
EcoR1 Capital
Vanguard Group
Farallon Capital Management
State Street Corporation
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
American Century Companies
T. Rowe Price Associates
Dimensional Fund Advisors
Bank of America Corporation
Vestal Point Capital
Federated Investors
AQR Capital Management

View all funds holding Voyager Therapeutics